Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 228

Similar articles for PubMed (Select 15240550)

1.

Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cells.

Katano K, Safaei R, Samimi G, Holzer A, Tomioka M, Goodman M, Howell SB.

Clin Cancer Res. 2004 Jul 1;10(13):4578-88.

2.

Intracellular localization and trafficking of fluorescein-labeled cisplatin in human ovarian carcinoma cells.

Safaei R, Katano K, Larson BJ, Samimi G, Holzer AK, Naerdemann W, Tomioka M, Goodman M, Howell SB.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):756-67.

3.

Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.

Samimi G, Safaei R, Katano K, Holzer AK, Rochdi M, Tomioka M, Goodman M, Howell SB.

Clin Cancer Res. 2004 Jul 15;10(14):4661-9.

4.

Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells.

Kalayda GV, Wagner CH, Buss I, Reedijk J, Jaehde U.

BMC Cancer. 2008 Jun 19;8:175. doi: 10.1186/1471-2407-8-175.

5.

Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.

Samimi G, Howell SB.

Cancer Chemother Pharmacol. 2006 Jun;57(6):781-8. Epub 2005 Sep 17.

PMID:
16170571
6.

Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells.

Holzer AK, Katano K, Klomp LW, Howell SB.

Clin Cancer Res. 2004 Oct 1;10(19):6744-9.

7.

Cross-resistance to cisplatin in cells with acquired resistance to copper.

Safaei R, Katano K, Samimi G, Naerdemann W, Stevenson JL, Rochdi M, Howell SB.

Cancer Chemother Pharmacol. 2004 Mar;53(3):239-46. Epub 2003 Nov 28.

PMID:
14648017
8.

The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells.

Katano K, Safaei R, Samimi G, Holzer A, Rochdi M, Howell SB.

Mol Pharmacol. 2003 Aug;64(2):466-73.

9.

Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B.

Samimi G, Katano K, Holzer AK, Safaei R, Howell SB.

Mol Pharmacol. 2004 Jul;66(1):25-32.

10.

Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper.

Katano K, Kondo A, Safaei R, Holzer A, Samimi G, Mishima M, Kuo YM, Rochdi M, Howell SB.

Cancer Res. 2002 Nov 15;62(22):6559-65.

11.

Transport of cisplatin by the copper efflux transporter ATP7B.

Safaei R, Otani S, Larson BJ, Rasmussen ML, Howell SB.

Mol Pharmacol. 2008 Feb;73(2):461-8. Epub 2007 Oct 31.

12.

Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines.

Yoshizawa K, Nozaki S, Kitahara H, Ohara T, Kato K, Kawashiri S, Yamamoto E.

Oncol Rep. 2007 Oct;18(4):987-91.

PMID:
17786364
13.

Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy.

Nakayama K, Kanzaki A, Terada K, Mutoh M, Ogawa K, Sugiyama T, Takenoshita S, Itoh K, Yaegashi N, Miyazaki K, Neamati N, Takebayashi Y.

Clin Cancer Res. 2004 Apr 15;10(8):2804-11.

15.

Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.

Wang W, Ke S, Chen G, Gao Q, Wu S, Wang S, Zhou J, Yang X, Lu Y, Ma D.

Oncol Rep. 2004 Dec;12(6):1365-70.

PMID:
15547764
16.

Cisplatin sensitivity of oral squamous carcinoma cells is regulated by Na+,K+-ATPase activity rather than copper-transporting P-type ATPases, ATP7A and ATP7B.

Ahmed Z, Deyama Y, Yoshimura Y, Suzuki K.

Cancer Chemother Pharmacol. 2009 Mar;63(4):643-50. doi: 10.1007/s00280-008-0781-z. Epub 2008 Jun 11.

PMID:
18545997
17.

Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug.

Leonhardt K, Gebhardt R, Mössner J, Lutsenko S, Huster D.

J Biol Chem. 2009 Mar 20;284(12):7793-802. doi: 10.1074/jbc.M805145200. Epub 2009 Jan 13.

18.

Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance.

Komatsu M, Sumizawa T, Mutoh M, Chen ZS, Terada K, Furukawa T, Yang XL, Gao H, Miura N, Sugiyama T, Akiyama S.

Cancer Res. 2000 Mar 1;60(5):1312-6.

19.

ATP7B antisense oligodeoxynucleotides increase the cisplatin sensitivity of human ovarian cancer cell line SKOV3ipl.

Xu W, Cai B, Chen JL, Li LX, Zhang JR, Sun YY, Wan XP.

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):718-22. Epub 2007 Oct 18.

PMID:
17944925
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk